Navigation Links
Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
Date:5/20/2008

Data on Newly-Approved Cimzia(R) Presented at Digestive Disease Week (DDW)

SAN DIEGO, May 20 /PRNewswire/ -- UCB announced today that data presented at Digestive Disease Week reaffirm the long-term, sustainable efficacy and safety of Cimzia(R) (certolizumab pegol) at stable doses in treating patients with moderate to severe Crohn's disease. Data also showed continued remission amongst the majority of responders and the remission rate remained stable in many of the patients who were re-induced with Cimzia(R). These results represent data from the PRECiSE trial program, which evaluated more than 1,300 patients receiving continuous treatment with Cimzia(R) (400 mg) for up to 18 months.

"The long-term Cimzia(R) data provide very important information for clinical practitioners treating people with Crohn's disease," said study investigator Gary R. Lichtenstein, M.D., professor of medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa. "In clinical trials, Cimzia(R) showed remarkable and sustainable long-term results without the need for dose escalation. Further, patients can achieve long-term symptom relief and remission regardless of the magnitude and rapidity of onset of the initial response."

Cimzia(R) is the first and only PEGylated anti-TNF (Tumor Necrosis Factor alpha) antibody approved for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy. Cimzia(R) was approved by the U.S. Food and Drug Administration (FDA) on April 22, 2008.

UCB, the manufacturer of Cimzia(R), presented analyses of the PRECiSE 3 and 4 open-label extension studies, which demonstrated the long-term efficacy of Cimzia(R) in treating Crohn's disease. PRECiSE 3 data showed that eight out of ten patients who were in remission at six months stayed in remission for up to 18 months. Furthermore, 35 percent of pat
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
2. Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
3. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
4. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
5. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
6. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
7. Gene Therapy Provides Vision to People who Were Nearly Blind
8. Arpida Provides Further Comments on the Pivotal Phase III Trials
9. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
10. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... NEW YORK , July 28, 2014 ... Global Bone Densitometers Market 2014-2018 ... Densitometry A bone densitometry scan is a special type ... of a bone. It is used primarily to detect ... is low and the risk of fractures is high. ...
(Date:7/28/2014)... -- June 28 th , 2014 – Oncolab, the ... cancer test, is making its AACC debut (booth #4051) at ... is a serum-based in vitro immunoassay, has been run for ... in the fight against cancer recurrence. Photo - ... million cancer survivors in the US alone, the race is ...
(Date:7/28/2014)... -- Surgical Theater, LLC announced today the addition of ... New members include Ori J. Braun , ... New Technologies for Given Imaging Ltd., and ... and General Manager of Philips Healthcare,s Computer Tomography ... to brain surgery and has developed software-based solutions ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5
... YORK, Oct. 25, 2011 ... market research report is available ... Neurology Devices Market to ... Usage of Neurostimulation Devices in ...
... Reportlinker.com announces that a new market ... Osteoporosis Therapeutics - Pipeline ... http://www.reportlinker.com/p0661232/Osteoporosis-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
Cached Medicine Technology:Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 2Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 3Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 4Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 5Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 6Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 7Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 8Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 9Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 10Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 11Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 12Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 13Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 11Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 12
(Date:7/29/2014)... Tucson-based company Outski has ... or health and wellness program, called 401(play)™. A 401(play)™ ... effective way for employees to use their earned vacation ... employees specify the amount of each paycheck to be ... benefits from offering a 401(play)™ plan to in several ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 Guests ... , will be indulged in a new sleep experience. The ... INTENTIONS™ Linens by Peacock Alley. , These expertly crafted, ... simple striped pattern from a distance, yet upon closer look, ... gentle reminders to relax, sleep and breathe. , ...
(Date:7/29/2014)... In his latest blog post at ... Per Wickstrom has listed 6 ways to light the “fire” ... and avoid complacency, but for some it’s a losing battle,” ... and powerful ways to help employees get to the next ... a whole.” , According to Per Wickstrom, 6 ways to ...
(Date:7/29/2014)... Creek, MI (PRWEB) July 29, 2014 ... program that gets clients off to a great start and ... in, was a proud sponsor of the National Cherry Festival ... MI. , The concert, which was co-sponsored by Miller Lite ... Soul take to the Pepsi Bay Side Music Stage presented ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... A U.S. District Court judge issued an injunction Thursday afternoon ... in wages for the state,s 400,000 home care workers. The injunction ... that were planning on passing the state cut through to their ... federal judge Claudia Wilken, was in response to a lawsuit filed ...
... Verathon Inc., maker of BladderScan(R) bladder volume instruments ... of Kendall Stever as Chief Financial Officer ("CFO"). ... oversight of the Company,s global financial affairs, including ... in Washington State, taxation, investor relations as well ...
... or hand changes shape, study finds, , THURSDAY, June 25 ... may do more than look for an easy par three. , ... of the body. , The mere act of holding a mechanical ... said Lucilla Cardinali, a graduate student in France and lead author ...
... 25 With thousands gathering in Washington to protest for ... Department Store Union (RWDSU, UFCW) is blasting US merchants for ... create." , , Union President Stuart Appelbaum,s comments came ... President Neil Trautwein to fight any health care reform legislation ...
... , ... have implications for gene,s role in other cancers , ... Washington, DC (Vocus) June 25, 2009 -- Research ... between mutations in the gene DICER1and cancer. By studying the patterns of DNA from ...
... WASHINGTON, June 25 In a 6-5 decision in ... of Appeals has upheld Virginia,s ban on partial birth infanticide -- ... , Americans United for Life (AUL) ... amicus brief supporting Virginia,s law. In addition, AUL ...
Cached Medicine News:Health News:Verathon Inc. Appoints Kendall Stever as Chief Financial Officer 2Health News:Grab a Tool and Change Your Brain 2Health News:Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 2Health News:Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 3Health News:Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute 2
... consisting of 38 cobbs, osteotomes, elevators, ... spine. The instruments extra (15) length ... best applied in thoracic, lumbar and ... for surgeons to pick and choose ...
... growth factors (AGF) technology. Using ... AGF gel delivers a cocktail ... and proteins in high concentrations ... of new bone cells and ...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution....
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: